Food and Healthcare Press Releases http://www.newswit.com/.food/ th-TH Wed, 26 Sep 2018 19:15:19 +0700 India Hosts the Mahatma Gandhi International Sanitation Convention http://www.newswit.com/.food/2018-09-26/cae5d1a6d824876128130ad886aac7bc/ Ministers and sanitation sector leaders from around the world will convene this month at the Mahatma Gandhi International Sanitation Convention (MGISC) in New Delhi. Hosted by the Government of India, this event will be an opportunity for delegates to http://www.newswit.com/.food/2018-09-26/cae5d1a6d824876128130ad886aac7bc/ Wed, 26 Sep 2018 8:10:24 +0700 Venus Medtech Launches Global Advisory Board to Target for International Market http://www.newswit.com/.food/2018-09-25/39dd483a718cacc1699110109d4c31a2/ Venus Medtech (Hangzhou) Inc., a Chinese medical device company specializing in transcatheter valve replacement therapy, has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board. The Board http://www.newswit.com/.food/2018-09-25/39dd483a718cacc1699110109d4c31a2/ Tue, 25 Sep 2018 8:39:45 +0700 Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare http://www.newswit.com/.food/2018-09-20/1dbd0df4ef5d967e5dabf79619050c58/ Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality http://www.newswit.com/.food/2018-09-20/1dbd0df4ef5d967e5dabf79619050c58/ Thu, 20 Sep 2018 14:05:00 +0700 PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims http://www.newswit.com/.food/2018-09-20/b5c10b88f27622e2877a794e99930efc/ In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group http://www.newswit.com/.food/2018-09-20/b5c10b88f27622e2877a794e99930efc/ Thu, 20 Sep 2018 11:53:35 +0700 Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting http://www.newswit.com/.food/2018-09-19/def32d2bfcbc6d966fc39e8171069a82/ Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular http://www.newswit.com/.food/2018-09-19/def32d2bfcbc6d966fc39e8171069a82/ Wed, 19 Sep 2018 8:24:42 +0700 Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice http://www.newswit.com/.food/2018-09-17/5904e7488dc60048d0baede095e845cd/ - Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report http://www.newswit.com/.food/2018-09-17/5904e7488dc60048d0baede095e845cd/ Mon, 17 Sep 2018 15:32:50 +0700 BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook http://www.newswit.com/.food/2018-09-17/4b01bc723942c1672661b802cc1a9d6c/ Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem http://www.newswit.com/.food/2018-09-17/4b01bc723942c1672661b802cc1a9d6c/ Mon, 17 Sep 2018 8:40:55 +0700 MEDICAL WINGS THAILAND BASED AIR AMBULANCE OPERATOR ACHIEVES FULL ACCREDITATION FROM CAMTS AND CAMTS EU AND BECOMES THE FIRST OPERATOR IN ASIA TO ACHIEVE THE #DUAL ACCREDITATION http://www.newswit.com/.food/2018-09-13/c0a63ea8aba07175701d36f05effd7fa/ Medical Wings, the air ambulance division of Siam Land Flying Company, a subsidiary company of Charoen Pokphand Group (C.P. Group), is proud to achieve full re-accreditation of its existing CAMTS approval as well as attaining the new CAMTS EU http://www.newswit.com/.food/2018-09-13/c0a63ea8aba07175701d36f05effd7fa/ Thu, 13 Sep 2018 11:27:16 +0700 Photo Release: CGH Group Hospital held the event Happy Life with Healthy Bone and Joints Seminar in Yangon, Myanmar. http://www.newswit.com/.food/2018-09-12/bef32b5a66959e86c6c34e8fbfe283c0/ CGH Group Hospital recently held a live health talk in Yangon, Myanmar to highlight the important health issues on bone and joints for all Myanmar people. A team of medical experts led by Dr. Wanchai Sirisereewan (4th from left), CGH#s Orthopedic Surgeon http://www.newswit.com/.food/2018-09-12/bef32b5a66959e86c6c34e8fbfe283c0/ Wed, 12 Sep 2018 12:02:24 +0700 BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study http://www.newswit.com/.food/2018-09-12/e936b5d859549c18e8959072f2b4786b/ - First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a regulatory submission in the US and http://www.newswit.com/.food/2018-09-12/e936b5d859549c18e8959072f2b4786b/ Wed, 12 Sep 2018 8:37:56 +0700 Syneron Candela Announces Acquisition Of Ellipse http://www.newswit.com/.food/2018-09-06/4112ea9daeb5f05964a4c8bd0da0229b/ - Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Syneron Candela#s portfolio, further strengthening their position in multi-application, multi-technology devices Syneron Candela, a leading global aesthetic device http://www.newswit.com/.food/2018-09-06/4112ea9daeb5f05964a4c8bd0da0229b/ Thu, 06 Sep 2018 9:09:18 +0700 ผลการทดลองสายสวนหลอดเลือดชนิดเคลือบยา Firehawk ได้รับการเผยแพร่ทางวารสารการแพทย์ The Lancet http://www.newswit.com/.food/2018-09-04/f0d3846dee03cb416c54e59ebd4be353/ MicroPort Scientific Corporation (MicroPort(R), HK:0853) ประกาศว่า ผลการทดลองสายสวนหลอดเลือดชนิดเคลือบยา Firehawk(R) Rapamycin Target Eluting Coronary Stent System (Firehawk(R)) ภายใต้โครงการทดลองแบบสุ่มและมีกลุ่มควบคุมในศูนย์หลายแห่งในชื่อ TARGET AC http://www.newswit.com/.food/2018-09-04/f0d3846dee03cb416c54e59ebd4be353/ Tue, 04 Sep 2018 14:56:10 +0700 Olon Acquires Manufacturing Facility in India http://www.newswit.com/.food/2018-09-04/8d6c4a9f3357089228eae2cc383e9ba4/ Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of a local generics chemical operations API manufacturing facility in http://www.newswit.com/.food/2018-09-04/8d6c4a9f3357089228eae2cc383e9ba4/ Tue, 04 Sep 2018 8:58:24 +0700 Firehawk Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet http://www.newswit.com/.food/2018-09-04/f1997c88ccdb896ad149588a82c997d5/ MicroPort Scientific Corporation (MicroPort(R), HK:0853) announced today that the clinical trial results for its Firehawk(R) Rapamycin Target Eluting Coronary Stent System (Firehawk(R)) which conducted a multi-center, randomized controlled trial http://www.newswit.com/.food/2018-09-04/f1997c88ccdb896ad149588a82c997d5/ Tue, 04 Sep 2018 8:10:54 +0700 Ozempic(R) Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Populations at High CV Risk Regardless of Prior CV Events at Baseline http://www.newswit.com/.food/2018-08-27/39697afb49aeeceb654f255321f585ae/ Ozempic(R) (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death (collectively termed major adverse cardiovascular events, MACE) in people with http://www.newswit.com/.food/2018-08-27/39697afb49aeeceb654f255321f585ae/ Mon, 27 Aug 2018 9:00:00 +0700 Singapore#s first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer http://www.newswit.com/.food/2018-08-20/c8f74d76bae6f48fbfd8c8df54c27d85/ Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer post-liver http://www.newswit.com/.food/2018-08-20/c8f74d76bae6f48fbfd8c8df54c27d85/ Mon, 20 Aug 2018 8:00:09 +0700 Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology http://www.newswit.com/.food/2018-08-16/34024a94abc8ca6fe6143762bcf066b4/ - Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company#s foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to http://www.newswit.com/.food/2018-08-16/34024a94abc8ca6fe6143762bcf066b4/ Thu, 16 Aug 2018 8:00:41 +0700 Kaneka officially starts continuous manufacturing under GMP http://www.newswit.com/.food/2018-08-14/b6075e2747eda83f51ef17682126276a/ Kaneka Corporation (Headquarters: Minato-ku, President: Mamoru Kadokura) have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: President: Kazuhiko http://www.newswit.com/.food/2018-08-14/b6075e2747eda83f51ef17682126276a/ Tue, 14 Aug 2018 15:18:56 +0700 TIENS Group opens new high-tech Experience Store in Shenzhen http://www.newswit.com/.food/2018-08-09/896a6367a26781906cb90d6fb3cae871/ TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on August http://www.newswit.com/.food/2018-08-09/896a6367a26781906cb90d6fb3cae871/ Thu, 09 Aug 2018 8:36:34 +0700 Sotera Health#s Nordion completes the sale of its medical isotopes business to BWXT http://www.newswit.com/.food/2018-08-07/4324ba1f0396e184956c01338fdd51c2/ - Nordion#s increased focus on gamma technologies supports Sotera Health#s company-wide commitment to Safeguarding Global Health(TM) Sotera Health LLC, the world#s leading, fully integrated protector of global health, today announced the closing of the http://www.newswit.com/.food/2018-08-07/4324ba1f0396e184956c01338fdd51c2/ Tue, 07 Aug 2018 8:27:23 +0700 Menarini Ricerche to Sponsor Cancer Trial in Acute Myeloid Leukemia in USA http://www.newswit.com/.food/2018-08-06/803d0d280a3eaa75d4e0ab41ee9a3e10/ Menarini Ricerche, a company of the Menarini Group, announced today that the sponsorship of the ongoing Phase I/II study that is investigating MEN1703/SEL24 for the treatment of patients with relapsed/refractory (R/R) AML in the USA has been transferred http://www.newswit.com/.food/2018-08-06/803d0d280a3eaa75d4e0ab41ee9a3e10/ Mon, 06 Aug 2018 11:32:00 +0700 Britannia Pharmaceuticals Ltd เผยผลการศึกษา TOLEDO เฟส 3 ชี้การใช้ยา Apomorphine ชนิดฉีดเข้าใต้ผิวหนังช่วยลดปัญหาอาการตอบสนองต่อยาไม่สม่ำเสมอในผู้ป่วยโรคพาร์กินสัน (PD) ซึ่งมีอาการที่ไม่สามารถควบคุมได้ด้วยการรับประทานยา http://www.newswit.com/.food/2018-08-06/4deb7858d7a7d8cedb0cfe756d64681b/ บริษัท Britannia Pharmaceuticals Ltd ได้เผยแพร่ผลการศึกษา TOLEDO (Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson#s Disease) แบบให้ยาจริงกับยาหลอกกับคนไข้ (double-blind phase) ในนิตยสาร Lancet http://www.newswit.com/.food/2018-08-06/4deb7858d7a7d8cedb0cfe756d64681b/ Mon, 06 Aug 2018 11:25:38 +0700 Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson#s Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication http://www.newswit.com/.food/2018-08-06/281d7ab16397d0ea17c9351e898e12c9/ Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet Neurology[1]. Treatment with APO-go(R)/MOVAPO(R) (apomorphine) subcutaneous infusion for 12 weeks gave significantly greater http://www.newswit.com/.food/2018-08-06/281d7ab16397d0ea17c9351e898e12c9/ Mon, 06 Aug 2018 11:25:36 +0700